3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
17
Colorectal Neoplasms
15
Colonic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
5
Brain Neoplasms
5
Skin Neoplasms
4
Rectal Neoplasms
4
Neoplasms
4
Lung Neoplasms
3
Neoplasm Metastasis
2
Gastrointestinal Neoplasms
2
Digestive System Neoplasms
2
Thyroid Neoplasms
1
Solid Tumors
1
Skin Diseases
1
Rectal Diseases
1
Pancreatic Neoplasms
1
Neurofibromatosis 1
1
Lymphatic Metastasis
1
Leukemia, Hairy Cell
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Hereditary Sensory and Autonomic Neuropathies
1
Gastrointestinal Diseases
1
Disease Progression
1
Digestive System Diseases
1
Colonic Diseases
1
Biliary Tract Neoplasms
1
Interventions
Temozolomide
18
Magnetic Resonance Spectroscopy
15
Specimen Handling
13
Radiotherapy
13
Radiation
9
Biopsy
5
pembrolizumab
4
Radiotherapy, Intensity-Modulated
4
Nivolumab
4
Bevacizumab
4
vorasidenib
3
trametinib
3
Surgical Procedures, Operative
3
Spinal Puncture
3
tovorafenib
2
dabrafenib
2
Restraint, Physical
2
Leukapheresis
2
Ipilimumab
2
Genetic Therapy
2
Fluorodeoxyglucose F18
2
Eflornithine
2
Craniotomy
2
Carboplatin
2
14-methyl-20-oxa-5,7,14,26-tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene
2
vocimagene amiretrorepvec
1
veliparib
1
trastuzumab deruxtecan
1
tocilizumab
1
ribociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Astrocytoma
×
encorafenib
×
1 year
×
Clear all
No trials found.